Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

ADP AdvancedMD Debuts New Patient Relationship Management (PRM) Suite

New PRM Suite Includes Check-in Kiosk, Automated Patient Forms and Patient Portal to Help Medical Practices Improve Patient Communications and Free Up Time for Proactively Managing Patient Healthcare Needs

South Jordan, Utah July 1, 2015 ADP® AdvancedMD®, a leader in all-in-one, cloud electronic health record (EHR), practice management, medical scheduling, medical billing services and a pioneer of big data reporting and business intelligence for smaller medical practices, today announced the launch of its new Patient Relationship Management (PRM) suite. The solution helps private medical practices streamline the patient intake process and the amount of time it takes to administer patient forms. PRM enables patients to easily complete forms electronically, and once finished, forms automatically and securely populate in patient charts, ensuring the medical staff has the most up-to-date information available on the patient.

“Private medical practices are extremely pressed for time and continually on the lookout for new tools and strategies to streamline the administrative side of things,” said Arman Samani, CTO, ADP AdvancedMD. “Our new Patient Relationship Management suite helps front office staff and administrators reduce the amount of time they spend on each patient’s paperwork and enables patients to utilize the Internet to complete intake forms electronically from the privacy of their home or the practice kiosk. This ensures the medical staff can enter a patient meeting informed and clearly focused on addressing the patient’s healthcare needs, and not searching for background information.”

The suite includes the AdvancedMD mobile patient and administrative check-in kiosk. The check-in kiosk, when combined with AdvancedMD insurance verification, credit card processing, as well as advanced online communications with patients, creates a full-featured front-office solution.

Other advantages of the ADP AdvancedMD Patient Relationship Management suite include:

  • Customizable patient and consent forms provide multiple workflow options for each practice. Private practice team members can assign intake forms and consent forms to the patient prior to their arrival at the office so they can be completed ahead of the appointment in the patient portal or in the waiting room via iPad.
  • Forms electronically load into the patient chart with no document scanning required. Additionally, the check-in kiosk lets the practice’s staff scan a patient driver’s license, review demographic information, and make any necessary updates.
  • Patient forms can be managed on an iPad with the iOS app or via traditional desktop browser. Both let the practice’s staff enter patient information, select documents for a patient, and setup an iPad kiosk to be utilized by a patient.
  • Staff are also able to view appointments by date, search for patients by name, view patient photo and demographic information, and add new and existing patient data to a record.
  • Once a patient form is completed, it automatically loads into the patient chart without the need for the office staff to scan paper documents.

Private practices can customize and bundle some or all of the products within the suite. AdvancedMDPRM is available now. To learn more and order, please click here.

AdvancedMD Resources­­­­­

About ADP

Employers around the world rely on ADP® (NASDAQ: ADP) for cloud-based solutions and services to help manage their most important asset – their people.  From human resources and payroll to talent management to benefits administration, ADP brings unmatched depth and expertise in helping clients build a better workforce.  A pioneer in Human Capital Management (HCM) and business process outsourcing, ADP serves more than 625,000 clients in more than 100 countries.  ADP.com

July 1, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

ALLSCRIPTS TAKES $200M EQUITY POSITION IN NANTHEALTH AND EXPANDS STRATEGIC ALLIANCE TO ENHANCEPRECISION GENOMIC MEDICINE AT POINT OF CARE

New Agreement Calls For Accelerating Delivery and Coordination of 21st Century Evidence Based Precision Medicine

CHICAGO and CULVER CITY, CA – June 30, 2015 – Allscripts (Nasdaq: MDRX) (“Allscripts”), a global leader in healthcare information technology solutions, and NantHealth, a cloud-based information technology company, announced they have taken a significant step forward in their strategic partnership through two cross-investments and a strengthening of their commercial agreement. The investments include Allscripts’ purchase of a 10% equity stake in NantHealth for $200 million in cash. In addition, NantCapital, LLC, the personal investment vehicle of Dr. Patrick Soon-Shiong, founder of NantHealth, has made a $100 million investment into Allscripts.

NantHealth is a healthcare IT company providing the most comprehensive genomic and protein-based molecular diagnostics testing in the market today through its first in class Genomic Proteomic Sequencing (GPS Cancer) diagnostic test, applying this actionable health information to create personalized cancer treatment plans through its sophisticated care planning tool Eviti. NantHealth is in the process of bringing GPS Cancer to the point of care and into the patient’s home through a single integrated clinical platform. The Company’s vision is to allow IDNs, Academic Medical Centers, Pediatric Centers, physicians, patients, payers, employers, researchers and pharma to coordinate personalized cancer care, enable access to cutting edge clinical trials, monitor outcomes and control cost in real-time.

The investments and commercial agreement strengthen the partnership between Allscripts and NantHealth, originally announced in March 2015, to develop an integrated, evidence-based, personalized approach to healthcare solutions, and specifically cancer care. The companies will use Allscripts’ scale, global network of hospital and physician clients and leading software solutions, combined with NantHealth’s clinical platform, applications and connectivity devices to build out the infrastructure for new personalized, precision medicine programs for our clients to improve cancer care.

Going forward, NantHealth and Allscripts are focused on working together to accelerate the dissemination of technologies that seamlessly bring the promise of comprehensive molecular diagnostics to the routine, patient care setting. Specifically, the companies intend to work on joint development of: API-based integration between the two companies’ solutions; the creation of a cross clinical-GPS Cancer sequencing knowledge ontology and industry standard; the development of GPS Cancer sequencing invitations via the Allscripts FollowMyHealth® solution; integration of NantTransporter giving access to NantCancer Genome Browser, NantContraster and Paradigm and the development of an ACO solution incorporating semantic interoperability.

Research has shown that a physician’s ability to make effective, evidence-based clinical decisions can improve by using specifically matched cancer protocols and drugs, delivered to the patient based on the individual’s unique DNA, RNA and proteomic profile, and integrated with the patient’s holistic clinical picture. http://www.ascopost.com/issues/june-25,-2015/redefining-cancer.aspx For the first time, NantHealth and Allscripts can integrate these two aspects into a unique knowledge-based solution to significantly improve the way clinicians treat cancer.

Together, physicians and patients will have the tools to stay engaged and active and provide necessary intervention as early as possible. Leveraging innovations in patient engagement, care coordination and disease management; NantHealth and Allscripts are creating the first fully comprehensive and integrated platform that will provide a transformation to the coordination and delivery of personalized care across the spectrum of integrated health systems, across community ambulatory and tertiary practices.

Paul M. Black, President and Chief Executive Officer of Allscripts, said, “We’re taking an important step forward in our strategic partnership that fully aligns our resources and furthers Allscripts’ strategy to invest in new technologies that can revolutionize service to hospitals and physicians. Under the leadership of Dr. Soon-Shiong, NantHealth is pioneering extraordinarily innovative, personalized healthcare solutions that will empower more efficient and effective clinical decisions. We’re confident that our joint efforts will help Allscripts lead the way in our vision of delivering an open, integrated and precision-based medical solutions to physicians and patients.”

Dr. Soon-Shiong stated, “Since the NantHealth/Allscripts partnership began earlier this year, we have come to know Allscripts and its management team well, and I am confident that they can be a major contributor toward the execution of our vision. Allscripts has the technology and scale to become a significant player in a once-in-a-generation shift to personalized medicine. Pursuing unique and innovative partnerships such as this, which can integrate our solutions across the full spectrum of precision care, furthers our mission of building a healthcare ecosystem to drive better outcomes with the highest quality and lowest cost.”

Provider Reaction

“North Shore-LIJ has an established commitment to oncology research and the delivery of world-class cancer care,” said Michael J. Dowling, president and chief executive officer of the North Shore-LIJ Health System. “Today’s announcement of an expanded strategic alliance between NantHealth and Allscripts is exciting, both in terms of furthering our clinical mission and the opportunity to generate additional value from our long-term partnership with Allscripts. We look forward to participating in this alliance as we work together to deliver on the potential for truly personalized care.”

“Today’s healthcare providers are looking for innovative solutions that are integrated across the continuum of care,” said Robert L. Meyer, president and chief executive officer of Phoenix Children’s Hospital. “Allscripts and NantHealth offer a promising vision for how tomorrow’ssolutions will provide healthcare professionals with a personalized, comprehensive view of the patient, better analyze data, create precise protocols to drive down costs and improve patient outcomes throughout our healthcare system.”

Allscripts Adds New Sunrise Hospital Client

Allscripts also announced today that Windber Medical Center, a nonprofit, community healthcare provider, NantHealth client and affiliate, has selected the Allscripts Sunrise™ platform to be the new core electronic health record for its hospital facility, replacing its current electronic health system. Located in Somerset County, in Southwestern Pennsylvania, Windber Medical Center offers comprehensive primary and acute care including a critical care unit, home health and hospice care
fitness and wellness programs as well as the Joyce Murtha Breast Care Center.

“Windber Medical Center together with the CAP certified and Platinum rated human tissue repository at the Windber Research institute and its partnership with Walter Reed Medical Center is poised to be an integrated cancer center with the most cutting edge scientific genomic research in cancer, and our affiliation with NantHealth and Allscripts will propel us towards our mission of providing 21st century care at the community level,” said Tom Kurtz, CEO of Windber Medical Center.

NantCapital Investment in Allscripts

NantCapital’s investment has been executed through a private placement of Allscripts common stock. Allscripts received gross proceeds of approximately $100 million in the private placement. The combined impact of the expanded commercial agreement and cross-investments is expected to be modestly accretive to Allscripts earnings in 2016 and become increasingly accretive over the five-year term of the commercial agreement. The transaction does not change Allscripts 2015 guidance.

###

About Allscripts
Allscripts (Nasdaq:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About NantHealth
NantHealth, a member of the NantWorks ecosystem of companies, is a healthcare transformational cloud-based IT company converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care, in the time of need, anywhere, anytime. NantHealth works to transform clinical delivery with actionable clinical intelligence at the moment of decision, enabling clinical discovery through real-time machine learning systems. The company’s technology empowers clinicians, patients and researchers to transcend the traditional barriers of today’s healthcare system. By converging molecular science, near real-time patient signal monitoring, computer science and big data technology, the NantHealth Clinical Operating System (cOS) platform empowers providers, patients, and commissioners to coordinate best care, monitor outcomes and control cost in real-time. This is the first system of its kind in healthcare, enabling 21st century coordinated care at a lower cost, enabling value-based population health management at a single patient level and at the population at large. For more information please visitwww.nanthealth.com and follow Dr. Soon-Shiong on Twitter @solvehealthcare.

About NantCancer Genome Browser
NantOmics, NantCancer Genome Browser enables clinicians for the first time to investigate a tumor genome from the full three billion bases down to the single-base level in real-time, thanks to the power of the NantOmics supercomputing and secure mobile infrastructure. The Cancer Genome Browser integrates with NantHealth’s treatment recommendation engine, Eviti, to personalize treatment protocols and clinical trail selection to individual patients based on their genomic and transcriptomic signature. The NantCancer Genome Browser is fully encrypted to allow deployment in a HIPAA secured environment, enabling clinicians to securely access patient data as soon as it’s available, wherever they
are.

About NantTransporter
Data transfer is one of the largest challenges associated with the analysis of sequencing data. NantOmics has designed an infrastructure capable of storing and processing thousands of genomes a day quickly and securely. Our NantTransporter software application enables secure transport of data directly from sequencing machines to NantOmics’s secure private genome processing cloud. Data streams are encrypted using 128-bit Advanced Encryption Standard (AES-128), the same algorithms designated for Top Secret government documents. Initiating a transfer is as easy as obtaining a transfer code from our web site, and specifying the files to be sent. Annotation of the genomes begins immediately with no downtime between transferring and the beginning of processing.

NantWorks has built a dark fiber network capable of Tb/sec transfers between hospitals, academic institutions and sequencing centers. In July 2012 we demonstrated the capabilities of NantTransporter by transferring 94 TB of genomic data and achieved speeds of up to 9.55 Gb/sec with a sustained rate of over 8.232 Gb/sec, the fastest and largest documented transfer of genomic data to date. To date we have transported over 15,000 cancer genomes via NantTransporter.

About NantContraster
Accurately assessing the state of a patient’s genome is one of the most powerful tools in the emerging field of personalized medicine. NantOmics applies its leading, novel genomic analyses to rapidly discover variants in a patient’s raw genomics data using the latest sequencing technologies combined with advanced statistics and machine learning techniques.

NantContraster annotates all variants against a knowledge database comprising all known and probable disease-associated genes to rank the genomic alterations that have the highest clinical relevance. When applied to cancer tumor/normal samples, our analysis is capable of quickly identifying genomic alterations that could lead to tumorigenesis for a fraction of the cost of conventional approaches. NantContraster is capable of concurrently processing many samples to handle large workflows from researchers and hospital settings.

About Paradigm
PARADIGM (Pathway Recognition Algorithm using Data Integration on Genomic Models) is a proprietary algorithm that uses a probabilistic graphical model to integrate multiple genomic data types on curated pathway databases and is unique for its per-sample approach that allows individual samples to be assessed alone or within the context of a cohort of interest.

June 30, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

HIMSS Survey Finds Two-Thirds of Healthcare Organizations Experienced a Significant Security Incident in Recent Past

Healthcare Organizations Implement New Technology and Personnel to Stay Ahead of Cyberattacks

CHICAGO (June 30, 2015– Cybersecurity was identified as an increased business priority over the past year according to 87 percent of respondents in the newly released 2015 HIMSS Cybersecurity Survey (http://www.himss.org/2015-cybersecurity-survey). Two-thirds of those surveyed also indicated that their organizations had experienced a significant security incident recently. Released at the Privacy and Security Forum, held in Chicago from June 30-July 1, this research reflects the continued cybersecurity concerns by healthcare providers regarding the protection of their organizations’ data assets.

“The recent breaches in the healthcare industry have been a wake-up call that patient and other data are valuable targets and healthcare organizations need a laser focus on cybersecurity threats,” said Lisa Gallagher, Vice President of Technology Solutions, HIMSS. “Healthcare organizations need to rapidly adjust their strategies to defend against cyber-attacks. This means implementing threat data,incorporating new tools and sophisticated analysis into their security process.”

The survey of 297 healthcare leaders and information security officers across the industry also found that at least half of respondents made improvements to network security, endpoint protection, data loss prevention, disaster recovery and IT continuity. Despite the protective technologies available, most respondents felt only an average level of confidence in their organizations’ ability to protect their IT infrastructure and data.

Key findings from the survey include the following:

  • Respondents use an average of 11 different technologies to secure their environment and more than half of healthcare organizations surveyed hired full time personnel to manage information security
  • 42 percent of respondents indicated that there are too many emerging and new threats to track
  • More than 50 percent of information security threats are identified by internal security teams
  • 59 percent of survey respondents feel the need for cross-sector cyber threat information sharing
  • 62 percent of security incidents have resulted in limited disruption of IT systems with limited impact on clinical care and IT operations
  • 64 percent of respondents believe a lack of appropriate cybersecurity personnel is a barrier to mitigating cybersecurity events
  • 69 percent of respondents indicated that phishing attacks are a motivator for improving the information security environment
  • 80 percent use network monitoring to detect and investigate information security incidents
  • 87 percent of respondents reported using antivirus/malware tools have been implemented to secure their healthcare organizations’ information security environment

In addition to the findings above, survey respondents found the following as the top ways security incidents were identified and the impact they had on their organizations:

To download the complete 2015 HIMSS Cybersecurity Survey, please visit: http://www.himss.org/2015-cybersecurity-survey

About HIMSS

HIMSS is a global, cause-based, not-for-profit organization focused on better health through information technology (IT). HIMSS leads efforts to optimize health engagements and care outcomes using information technology.

HIMSS is a cause-based, global enterprise producing health IT thought leadership, education, events, market research and media services around the world. Founded in 1961, HIMSS encompasses more than 58,000 individuals, of which more than two-thirds work in healthcare provider, governmental and not-for-profit organizations across the globe, plus over 640 corporations and 400 not-for-profit partner organizations, that share this cause.  HIMSS, headquartered in Chicago, serves the global health IT community with additional offices in the United States, Europe, and Asia.

I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

CynergisTek Expands Leadership Team to Support Company Growth

Adam Hawkins Advances as Vice President of Sales and Marketing to Drive Continued Expansion Amid Increased Demand for Privacy and Security Expertise in Healthcare

Austin, Texas, June 29, 2015CynergisTek™, an authority in health information privacy, security and compliance, today announced it has expanded its leadership team with the addition of Adam Hawkins as Vice President of Sales and Marketing. Effective July 1, 2015, Adam will be responsible for the sales and marketing operations at CynergisTek, as well as the strategic planning, development and implementation of the company’s Managed Services and Vendor Security Management offerings. In addition, Adam will continue to ensure a high-level of support is maintained across the company’s client base of healthcare provider organizations. Adam originally joined CynergisTek as Director of Client Services in 2012, and was an integral part of developing a highly successful sales team as the company restructured its sales and marketing efforts from the ground up.

Adam’s transition to this executive role will be critical in effectively managing unprecedented company growth spurred by increased demand for privacy and security expertise in healthcare. The company has experienced a 70 percent increase in revenue over the last calendar year, and has rapidly expanded its workforce, requiring seasoned leadership in sales, marketing and client services. Adam has more than a decade of experience in healthcare information security and clinical technologies, positioning him well to manage the company’s sales force, marketing department and partner alliances.

“Adam’s commitment to matching providers with the best possible solutions for their privacy and security needs has been instrumental in fostering the trust our clients have come to know and rely on us for,” said Dr. Michael Mathews, CynergisTek Co-Founder and COO. “Adam has a proven track record of ensuring client success, and we are pleased to have him join the executive team where he can exercise his leadership skills and provide strategic direction as we continue to grow.”

Complex regulations, looming enforcement action and prevalent data breaches in the healthcare industry have made data security a top priority for most providers. This increased focus on information security has led many organizations to seek outsourced expertise, driving business for CynergisTek and opening the door to new career opportunities at the company for those with education and experience in information technology.

“It’s been the opportunity of a lifetime to be a part of a company that is leading the healthcare industry at such a critical time,” said Adam. “It has been very rewarding to help CynergisTek clients navigate today’s dynamic threat environment, and I am looking forward to stepping into my new role where I can fully dedicate myself to adding value across the board.”

Prior to joining CynergisTek, Adam was a Regional Sales Executive at Diebold and DrFrist and Director of Sales & Technology at VisionTree. Adam holds a Bachelor’s of Science in Information and Decision Systems and Political Science from California State University, San Diego.

About CynergisTek

CynergisTek is a top-ranked information privacy and security consulting firm. The company offers solutions to help organizations measure privacy and security programs against regulatory requirements and assists in developing risk management best practices. Since 2003 the company has served as a partner to hundreds in the healthcare industry. CynergisTek is also dedicated to supporting and educating the industry by contributing to relevant associations such as HIMSS, AHIMA, HFMA, HCCA, AHIA, AHLA, IAPP and CHIME. CynergisTek was recognized by KLAS®, as one of three firms provider organizations turn to most for privacy and security assistance in its groundbreaking report released in May 2014, entitled “Security and Privacy Perception 2014: High Stakes, Big Challenges.” For more information visitwww.cynergistek.com, call 512.402.8550 or email info@cynergistek.com.

June 29, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Survey Shows Insider Threats on the Rise: Organizations Experience an Average of 3.8 Attacks per Year

Survey by Crowd Research Partners Shows Endpoints Are by Far the Most Common Launch Point for an Insider Attack; Highlights Need for Robust Endpoint Security and Policies

VERO BEACH, FL − (June 24, 2015)SpectorSoft™, a leader in the user activity monitoring and behavior analysis market, today released results of the Insider Threat Report, a crowd-based research project that was done in cooperation with the 260,000+ member Information Security Community on LinkedIn and Crowd Research Partners to gain more insight into the state of insider threats and solutions to prevent them. The final report results were based on a comprehensive survey of over 500 cybersecurity professionals from organizations of varying sizes across many industries; the results highlight the increasing need for better security practices and solutions to reduce the risks posed by insider threats.

Among the report’s findings:

The Rise of Insider Attacks: A majority of security professionals (62 percent) saw a rise in insider attacks over the last 12 months, while 22 percent saw no rise, and 16 percent were unsure if they had been attacked or not.

Frequency of Insider Attacks: Forty-five percent of respondents cannot determine whether their organizations experienced insider attacks in the last 12 months. Twenty-two percent said they experienced between one and five attacks, and 24 percent of organizations believe they experienced no attacks at all. Of the respondents who were willing to admit they suffered an insider attack, the average number was 3.8 incidents per organization per year.

Cost of Remediation: The overall average cost of remediating a successful insider attack is around $445,000. With an average risk of 3.8 insider attacks per year, the total remediation cost of insider attacks can quickly run into the millions of dollars.

Monitor Insider Activity on the Endpoint: The survey highlights the need for robust endpoint security and policies; respondents identified endpoints as the most common launch point for insider attacks (56 percent); this was followed by networks (43 percent) and mobile devices (42 percent).

Top Insider Threats: Organizations overwhelmingly maintained that data loss was the top concern regarding insider threats. When asked which types of insider attacks were most concerning, 63 percent of respondents said data leaks, 57 percent said inadvertent data breaches and 53 percent said malicious data breaches.

Vulnerable Data: Sixty-four percent of respondents feel extremely, very or moderately vulnerable to insider threats. Due to its value to attackers, the most vulnerable type of data is customer data (57 percent). This was closely followed by intellectual property (54 percent) and financial data (52 percent).

Internal versus External Attacks: Sixty-two percent of respondents find it more difficult to detect internal threats than external threats, while 38 percent cannot determine which type of threat is most difficult to detect.

Monitoring the Threat: When it comes to threat monitoring, 75 percent of companies monitor the security controls of their applications, 60 percent monitor a majority of all of their key IT assets, while only 21 percent continuously monitor user behavior taking place on their networks.

“The survey and report called out a rise in insider threats, the difficulty in detecting them, and the significant costs in cleaning up after a successful insider attack,” said Mike Tierney, COO, SpectorSoft.  “Companies need the ability to detect for anomalies in user behavior to make sure they are aware of the threats that exist within their organizations, because insiders will deviate from their normal behavior patterns when planning and executing an attack.”

About SpectorSoft

SpectorSoft is the leader in user activity monitoring and an innovator in user behavior analysis software. SpectorSoft has helped more than 36,000 businesses, government organizations, schools and law enforcement agencies improve how they address security and achieve compliance. SpectorSoft award-winning solutions include enterprise-grade insider threat detection software, a powerful user activity monitoring solution deployed by thousands of companies in more than 110 countries, robust Event and Security Log Management, and the world’s leading employee investigation tool. For more information, please visitwww.spectorsoft.com.

June 26, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Zoeticx Leverages Crowd Funding to Introduce TruRecord, Medical Prescribing Software That Will Address 2.2 Million Adverse Drug Reactions in U.S.

First EHR-integrated, Precise and Personalized, Mobile Platform to Leverage Advances in DNA Testing for Better Patient Outcomes and Lower Malpractice Payouts

June 29, 2015; San Jose, Calif — Zoeticx, Inc., the developer of medical software that bridges the gap between medical data and quality patient care, today announced a crowd funding campaign for TruRecord, the first subscriber-based, medical prescribing software to leverage advanced DNA testing technology for optimal drug analysis and prevention of adverse drug reactions.

The company is raising funds for a fall launch of TruRecord on medical crowd funding site Medstartr http://www.medstartr.com/projects/662-trurecord

TruRecord improves patient outcomes by reducing the 80,000 annual deaths due to drug adverse reactions, resulting in 289 billion spent annually on malpractice payouts. CDC ranks this as the fourth highest cause of deaths in US. With 30 new medications introduced yearly and 25 percent of patients on multiple medications, the need is growing.  The CDC also ranks this as the fourth highest cause of death in the U.S. after heart disease, cancer and strokes.

TruRecord is designed to foster better patient outcomes by helping to prevent the 100,000 deaths yearly from drugs that are prescribed properly and 80,000 deaths from those which are not, resulting in 289 billion spent annually on malpractice payouts.

Breaking Through Drug Analysis Limitations

Through an intuitive visualization of drug-to-drug interactions, drug-to-allergy interactions, and drug to DNA metabolization, medical professionals can now create what-if scenarios for drug issues, enabling providers to personalize prescriptions. This capability breaks through providers’ drug analysis limitations and the burdensome task of scanning and searching text and tables to identify adverse reaction data which is often complex.

These scenarios can now also be more complete with accurate patient medical information from any facility, including integration from existing hospital EHR’s through Zoeticx’s Patient-Clarity Platform which connects disparate EHR records and enables medical system interoperability.

Mobile Devices, HIPAA Compliance

TruRecord client interfaces are supported on mobile and web interfaces, providing precise, personalized medication prescriptions. TruRecord accesses patient medical records via an on-demand, real time access from EHR / EMR systems. Without data duplication, TruRecord complies with all required secure patient privacy protection outlined by HIPAA.

“We built Zoeticx to help medical systems address interoperability, lower accidental deaths and bridge the gap between medical data and better patient outcomes,” said Thanh Tran, CEO, Zoeticx. “Today our goal is the same, but a shift toward an additional focus—adverse drug reactions. We are ushering in an era where we can leverage the fruits of DNA research to bring more precise and accurate prescriptions to those who rely on them. TruRecord takes the guess work out of drug interactions and patients by delivering security, peace of mind and accuracy.”

About Zoeticx

Zoeticx offers software solutions for the healthcare industry which are dedicated to improving patient outcomes, enhancing the quality of care, containing costs, and simplifying administration. These solutions offer an immediate increase in the quality of care by delivering the right information to the right caregiver at the right time, in a manner that can be easily understood.  Additionally, as the Affordable Care Act continues to roll out, healthcare providers will face new challenges which arise whenever there is a transition from an old system of doing business to a new one. Zoeticx helps solve those challenges, allowing care providers to focus on what is most important, the patient. www.Zoeticx.com For additional information contact Glass Lantern PR at @glasslanternpr.com.

June 25, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Boston-Based Myelin Communications Acquires Dodge Communications

HY Connect and Dodge Communications Will Bring Expanded Marketing and Public Relations Services to Healthcare and Financial Services Clients  

Boston, Mass. (June 23, 2015) – Myelin Communications, a growing network of communications firms linked by experience in the healthcare and financial services sectors, announced today the acquisition of HY Connect, an advertising agency in Chicago, and Dodge Communications, a public relations and integrated communications firm in Atlanta. Rich Levy, CEO of Myelin, a Baird Capital portfolio company, will become chairman of both companies.

“While most companies in our industry are focused on growth in terms of size, Myelin Communications’ growth is fueled by teaming with companies that will enable us to provide deeper, richer and more comprehensive service offerings for clients,” said Rich Levy. “HY Connect and Dodge Communications are both directly aligned with the Myelin vision, and we look forward to working together to support our clients’ success.”

HY Connect, which specializes in understanding the unique challenges that face chief marketing officers, is one of the largest, independent communications agencies in Chicago. With a full suite of services, HY Connect delivers integrated strategies throughout multiple disciplines and offers digital, creative, brand strategy, social media and research services.

“Myelin’s network will bring a host of new resources and expertise to HY Connect,” said Dave Sheehan, president of HY Connect. “This is an important growth opportunity for HY Connect, and we’re very pleased to join this collaborative partnership.”

Focused solely on healthcare since its founding in 2001, Dodge Communications has built an impressive client roster featuring some of the largest brands in the industry. The company serves as a strategic asset for these clients, providing support in key areas such as public relations, social media, content development, and creative and digital services.

“Being part of Myelin Communications provides an exciting opportunity for our clients and employees,” said Brad Dodge, president and founder of Dodge Communications. “We look forward to exchanging best practices and expertise with such a strong network of firms that share our passion for healthcare.”

Based in Boston, Myelin is comprised of five companies: PARTNERS+simons, a Boston-based brand communications and integrated marketing services firm specializing in healthcare and financial services; Duet Health, a Columbus-based mobile communication platform serving hospitals, health systems and general health providers; AVID Design, an Atlanta-based online marketing communication business with an extensive healthcare website design and content management system presence; Dodge Communications, an Atlanta-based, healthcare focused integrated marketing and public relations company; and HY Connect, a Chicago-based integrated marketing agency.

About Myelin

Just as myelin insulates and strengthens connections between the brain’s neurons, making them more powerful message conductors, Myelin Communications is a unique network of companies specializing in health and financial services. For a growing portfolio of payer, provider, medical, financial and wealth management organizations, Myelin creates connections that can make message platforms even more powerful. Our capabilities include brand development and activation, market research, channel planning and media solutions, integrated creative and marketing content, digital technology solutions, sales enablement, data analytics, mobile engagement, measurement strategies and more. More information is available at http://www.myelincommunications.com/

June 23, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Nebraska Medicine and Epic ahead of their time with a new patient engagement app for the Apple Watch

Information about appointments, medications and more coming to the wrists of patients with Apple’s newest device

Omaha, Neb – Apple has always been about innovation. The same can be said for Epic, the Verona, Wisconsin-based healthcare software company whose customers manage medical records for more than half the U.S. population, including patients at Nebraska Medicine. Now, Epic and Nebraska Medicine announce one of the first efforts to improve the patient experience using Apple’s first wearable device.

“We’re always looking for ways to improve the satisfaction of our patients,” said Michael Ash, M.D., chief transformation officer at Nebraska Medicine. “We recognize that as more of our patients use devices like the Apple Watch, we not only have to be able to use that technology to initially provide convenience for them, but we also have to envision how we can also improve patient outcomes via use of the device in the future.”

Epic’s MyChart app for Apple Watch, available now on the App Store, lets patients view messages from their care providers, upcoming appointment details, and information on their active medications. They can also see notices when new test results, billing statements and health maintenance reminders are accessible on their iPhones.

“It’s great to see Nebraska Medicine help lead the way on patient engagement with the Apple Watch,” says Sumit Rana, Epic’s senior vice president for research and development. “Wearables such as the Apple Watch have great potential to empower patients as active participants in their own healthcare and wellness while improving the overall care experience.”

Epic has development in the works based on the Apple Watch’s ability to “tap” wearers on the wrist to get their attention. Diabetic patients will be able to get reminders to test their blood sugar regularly, for example. Care organizations will also be able to use the watch to help patients get quicker access to high-demand specialty visits and services. Epic’s Fast Pass On the Go feature would allow a patient with an appointment three weeks out to get an Apple Watch alert if an earlier slot opens up – when another patient cancels an appointment, for example – and accept the new appointment time from the watch.

An Apple Watch app is also available for physicians who use Epic’s Haiku mobile application for the iPhone. Doctors can view their schedule, hospitalized patients and clinical summaries. They can also use Siri’s speech-to-text functionality to record a clinical note or a MyChart message to send to a patient.

Nebraska Medicine is the most esteemed academic health system in the region offering exceptional patient care combined with innovative research and education. Committed to advancing quality health care, Nebraska Medicine represents the clinical integration of The Nebraska Medical Center, the state’s largest and highest rated hospital, Bellevue Medical Center and UNMC Physicians. Our newly integrated organization allows us to strengthen our services by expanding collaboration with our partners and providing patients access to more than 1,000 physicians and 678 licensed hospital beds as well as approximately 40 specialty and primary care clinics in Omaha and the surrounding area. Find Nebraska Medicine online at www.nebraskamed.com.

June 19, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Vocera Clinical Workflow Engine Improves Clinical Integrations and Reduces Costs

SAN JOSE, Calif., June 16, 2015 (GLOBE NEWSWIRE) — Mobile healthcare communications company, Vocera (NYSE:VCRA), today introduced the Vocera Clinical Workflow Engine to streamline integrations between the Vocera Communication System and clinical systems such as nurse call and electronic health records (EHRs). By integrating Vocera with these and other solutions, hospitals can automatically send an alert to the nurse assigned to a particular patient based on the intelligent workflow defined in the system, improving patient safety and reducing the noise and annoyance of broadcast alarms.

Vocera’s Clinical Workflow Engine eliminates the need for third-party middleware. It streamlines clinical workflows for voice, messaging, patient monitoring alerts and alarms, nurse calls, EHRs, bed management and other clinical systems. As part of the Vocera Communications System, this solution also reduces costs and the number of vendors required to support clinical workflows, simplifying care team collaboration.

A recent Vocera study sent to nearly 500 high-level hospital employees, conducted by TechValidate, showed 84 percent of respondents find value in Vocera integrations with patient monitoring; 75 percent find value in Vocera’s ability to integrate with EHRs; and 87 percent indicated that Vocera integrations with nurse call systems were important.1 This workflow solution gives Vocera users the ability to deliver the right information, to the right person, on the right device, at the right time.

Using the Vocera Clinical Workflow Engine as the single source of information exchange improves accuracy and consistency within the communication data flow, and enables advanced workflow capabilities in reporting and analytics. For example, by integrating alert and alarm systems with the Vocera Clinical Workflow Engine, care teams can better understand alarm trends and identify potential workflow gaps with detailed analytics filtered by bed, unit, staff, alarm type, alarm density, distribution and response time. Between 72 and 99 percent of all clinical alarms do not require clinical intervention so this contextual data plays a crucial role in improving patient safety and care team efficiency while reducing the growing concerns of alarm fatigue.

“Real-time communication requires seamless integration between systems to ensure clinicians have the right information at the right time to optimize workflow, improve patient care and safety, and reduce costs,” said Gautam M. Shah, vice president of product management at Vocera. “The Vocera Clinical Workflow Engine allows the Vocera Communication System to operate as a single-source for clinical integrations, simplifying and improving the accuracy and efficiency of communication, data flow, reporting and analytics.”

For more about Vocera Clinical Workflow Engine, please visit http://www.vocera.com/resource/vocera-clinical-workflow-engine-solution-brief.

About Vocera

Vocera Communications, Inc. (NYSE:VCRA) is a mobile healthcare communications company that provides enterprise-class solutions. Widely recognized for developing smarter ways to communicate, Vocera helps care teams collaborate more efficiently by delivering the right information, to the right person, on the right device, at the right time, anywhere. Vocera solutions are installed in more than 1,200 organizations worldwide, improving quality, efficiency, safety and outcomes. Via the company’s research collaborative, the Experience Innovation Network, Vocera also drives thought leadership for the healthcare industry and new standards in care delivery to elevate patient, family, nurse and physician experiences. Vocera is headquartered in San Jose, California, with offices in San Francisco, Tennessee, Canada, India, United Arab Emirates, and the United Kingdom. For more information, visit www.vocera.com and @VoceraComm on Twitter.

1 Source: TechValidate. http://www.techvalidate.com/product-research/vocera-communication-system

June 16, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

Dell and Translational Genomics Research Institute Help Support the Fight Against Pediatric Cancer Across Europe and the Middle East

DELL INNOVATION DAY, COPENHAGEN, Denmark, June 11, 2015 — Dell today announced its extended partnership with Translational Genomics Research Institute (TGen) to help clinical researchers and doctors globally expand the reach and impact of the world’s first Food and Drug Administration (John,FDA)-approved personalized medicine trial for pediatric cancer. The renewed commitment includes an additional $3 million Dell grant to support continued collaboration with TGen and support theNeuroblastoma and Medulloblastoma Translational Research Consortium’s (NMTRC) expanded  pediatric cancer clinical trials in EMEA, starting with sites in France and Lebanon. This is the second grant Dell has provided TGen to accelerate treatment of pediatric cancer, bringing its total contributions to more than $15 million since 2011.

The grant will also allow TGen to use Dell technology to bring genomic sequencing to point of diagnosis and enable TGen to extend its capabilities past pediatric cancer to support sequencing for other medical conditions affecting children including rare childhood diseases. By leveraging the capacity of Dell’s technology infrastructure, TGen is able to redirect some of its attention and resources to research rare disease sequences and help families get answers more quickly.

With most large hospitals lacking the time and budget to research pediatric cancer treatments, TGen’s aim is to reach and treat as many children as possible. However, when looking to support patients globally, it realized that it could no longer manage all of its data processing from the US. With time running out for many of its patients, TGen needed a solution that it could trust and that would reduce the amount of time needed to find and sequence genomic data. Based on a successful partnership in the US, TGen and Dell decided to extend its partnership and expand its support to EMEA.

“Time is of the essence in our line of work so we’re constantly undergoing vendor evaluations to try to find the right tool for the job. Dell understands what we’re trying to accomplish – not an easy claim in the world of quick-fire genome sequencing – and it has the partnerships and hardware to help us do it,” said James Lowey, Vice President of Technology, TGen.

TGen’s extended partnership with Dell will help it optimize a high-performance computing infrastructure to enable researchers to analyze and store massive amounts of genetic data more quickly and reach more patients than ever before. To date, TGen has been able to increase the number of computational hours by 376 percent and reduce the time it takes to analyze a patient’s molecular data – a process that used to take ten days – to six hours. These results will now be replicated in EMEA, as the infrastructure scales easily to handle the increased number of patients across the new sites.

“We are proud to help TGen in EMEA gain the speed and efficiency it needs to ensure that more children can benefit from timely, local and effective treatment.  Pediatric cancer is an issue that affects too many lives and we are committed to delivering benchmark solutions and support to ensure that the team at TGen are able to focus on this most important of work,” said Aongus Hegarty, President, Dell EMEA.

About Dell

Dell Inc. listens to customers and delivers innovative technology and services that give them the power to do more. As one of the leading providers of end-to-end IT solutions for healthcare worldwide, Dell helps healthcare organizations to simplify administration; coordinate and manage patient care; transition from episodic care to prevention and wellness management; and ultimately to deliver personalized medicine. As part of the company’s commitment to put technology and expertise to work where it can do the most good for people and the planet, Dell has been working with TGen since 2011 to accelerate pediatric cancer treatment. Learn more at http://www.dell.com/childrenscancercare or follow @DellHealth on Twitter.

About TGen

Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit).  TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: www.tgen.org.

June 11, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 10 blogs containing over 8000 articles with John having written over 4000 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 16 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.